HSR21-069: Factors Associated With Time to Treatment With an EGFR-TKI Among Patients With Non-Squamous Metastatic Non-Small Cell Lung Cancer: A SEER-Medicare Analysis

Authors :: Laura Q.M. Chow
Elizabeth Marrett
Winghan Jacqueline Kwong
Chunlin Qian
Source :: Journal of the National Comprehensive Cancer Network. 19:HSR21-069
Publication Year :: 2021
Publisher :: Harborside Press, LLC, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Time to treatment
Seer medicare
medicine.disease
Egfr tki
Non squamous
Internal medicine
medicine
Non small cell
business
Lung cancer

Full Text Access

Tools